In this issue:
Preoperative frailty, operative stress and postoperative mortality
US national Veterans data on abiraterone and enzalutamide
GnRH agonist vs antagonist and preexisting cardiovascular disease
Prostate mpMRI and negative prostate biopsy but elevated PSA
Hemigland cryoablation of localised prostate cancer
Trends in initial management of CRPC
Intensity-modulated fractionated vs stereotactic body radiotherapy
Mortality and metastasis with different active surveillance biopsy frequencies
Enzalutamide plus ADT in metastatic hormone-sensitive prostate cancer
Outcomes in men with low PSMA expression and metastatic CRPC
Please login below to download this issue (PDF)